REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
8.82
-0.24 (-2.65%)
At close: Aug 15, 2025, 3:59 PM
8.91
0.96%
After-hours: Aug 15, 2025, 06:29 PM EDT

REGENXBIO Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-175.57M -157.69M -227.1M -238.81M -241.08M -260.15M -263.49M -260.54M -274.16M -270.27M -280.32M 73.64M 90.72M 101.26M 127.84M -212.42M -145.23M -121.35M
Depreciation & Amortization
15.84M 15.99M 16.21M 16.53M 16.94M 17.32M 17.32M 17.11M 16.29M 14.5M 12.91M 11.39M 10.67M 10.23M 9.56M 9.06M 8.41M 8.34M
Stock-Based Compensation
36.62M 37.4M 38.46M 37.26M 37.59M 38.66M 40.27M 41.34M 41.36M 41.19M 40.79M 40.54M 40.03M 39.69M 38.81M 37.23M 35.53M 33.85M
Other Working Capital
28.76M 46.53M 2.24M 6.39M -3.4M -21.95M -32.16M -36.74M -39.11M -32.71M -13.11M 15.75M 18.61M 25.11M 456.18M 427.57M 427.56M 415.82M
Other Non-Cash Items
-5.04M 23.38M 27.31M 45.62M 53.44M 15.35M 12.76M 340K 755K 2.48M 3.87M -18.02M -11.21M -6.13M -984K 21.22M 12.92M 6.11M
Deferred Income Tax
n/a n/a n/a -12.42M -14.76M -14.38M -14.38M -1.96M 380K n/a n/a n/a n/a 1.58M 3.43M -9.2M 6.36M 539K
Change in Working Capital
40.26M 36.23M 11.66M 9.22M -3.59M 10.57M -10.89M -13.31M -2.7M -21.68M 13.98M 49.28M 40.72M 57.47M 40.22M 86.22M 14.01M 12.89M
Operating Cash Flow
-87.89M -84.04M -173.13M -182.26M -191.12M -192.94M -218.41M -217.02M -218.07M -232.5M -207.49M 158.12M 172.22M 204.09M 218.88M -67.89M -68M -59.62M
Capital Expenditures
-2.82M -2.9M -2.44M -2.48M -3.6M -5.7M -9.96M -14.3M -17.91M -24.57M -30.72M -39.87M -53.52M -64.12M -84.17M -82.45M -69.82M -53.26M
Cash Acquisitions
n/a n/a n/a -35.1M -75.2M -132.99M -132.99M -97.89M -115.89M -58.09M -58.09M -63.08M -4.99M -4.99M -4.99M n/a n/a n/a
Purchase of Investments
-282.72M -154.11M -190.14M -192.56M -174.49M -141.75M -86.56M -79.89M -76.31M -55.39M -184.88M -408.38M -414.51M -394M -498.14M -306.34M -294.37M -325.98M
Sales Maturities Of Investments
280.38M 292.01M 296.02M 292.19M 263.63M 288.49M 287.47M 277.86M 292.28M 221.72M 203.67M 193.26M 176.1M 175.07M 175.68M 210.07M 203.38M 255.1M
Other Investing Acitivies
n/a 206K 13.95M 49.05M 89.14M 146.73M 200.9M 165.8M 183.8M 134.16M -13.38M -8.38M -31.68M -12.19M -115.73M -96.26M -90.99M -70.87M
Investing Cash Flow
-5.16M 135.01M 103.45M 97.15M 85.55M 141.03M 190.94M 183.67M 198.06M 141.76M -11.93M -254.99M -291.93M -283.05M -406.64M -178.71M -160.82M -124.13M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
307K 307K n/a n/a n/a n/a n/a n/a n/a n/a n/a -2K -2K -2K -2K 1.8M 1.8M 1.8M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
114.29M -34.39M -39.58M -43.8M -37.5M -37.22M -35.55M -32.51M -34.24M -32.75M -30.58M -14.02M -10.9M -9.37M -7.7M 178.83M 182.52M 190.48M
Financial Cash Flow
114.84M -33.84M 92.68M 88.46M 94.51M 94.8M -34.97M -31.92M -32.54M -31.04M -28.84M -27.54M -24.4M -22.87M 195.25M 397.03M 400.78M 408.74M
Net Cash Flow
23.82M 19.16M 25.03M 5.6M -10.84M 43.11M -62.2M -65.27M -52.55M -121.78M -248.26M -109.14M -135M -98.91M 7.48M 135.17M 162.85M 222.07M
Free Cash Flow
-90.71M -86.94M -175.56M -184.74M -194.72M -198.64M -228.37M -231.32M -235.98M -257.07M -238.21M 118.25M 118.7M 139.97M 134.7M -150.34M -137.82M -112.88M